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Abstract 22
Fragile X mental retardation 1 (FMR1) encodes the RNA binding protein FMRP. Loss of FMRP 23
drives Fragile X syndrome (FXS), the leading inherited cause of intellectual disability and a 24 leading monogenic cause of autism. Cortical hyperexcitability is a hallmark of FXS, however, 25 the underlying mechanisms reported, including alterations in synaptic transmission and ion 26 channel expression and properties, are heterogeneous and at times contradictory. Here, we 27 generated isogenic FMR1 y/+ and FMR1 y/human pluripotent stem cell (hPSC) lines using 28 CRISPR-Cas9, differentiated these stem cell tools into excitatory cortical neurons and 29 systematically assessed the impact of FMRP loss on intrinsic membrane and synaptic properties 30 over the course of in vitro differentiation. Using whole-cell patch clamp analyses at five separate 31 time-points, we observed significant changes in multiple metrics following FMRP loss, including 32 decreased membrane resistance, increased capacitance, decreased action potential half-width and 33 higher maximum frequency, consistent with FMR1 y/neurons overall showing an increased 34 intrinsic membrane excitability compared with age-matched FMR1 y/+ controls. Surprisingly, a 35 majority of these changes emerged early during in vitro differentiation and some were not stable 36 over time. Although we detected significant differences in intrinsic properties, no discernable 37 alterations were observed in synaptic transmission. Collectively, this study provides a new 38 isogenic hPSC model to study the mechanisms of FMR1 gene function, identifies 39 Introduction 44 Fragile X syndrome (FXS) is caused by a repeat expansion in the 5'UTR of Fragile X mental 45 retardation 1 (FMR1), leading to loss of Fragile X mental retardation protein (FMRP)(1-3). 46
Studies using EEG and fMRI have revealed significant differences in cortical excitability 47 between FXS patients and unaffected controls (4-6). Paralleling these results, a large body of 48 experimental research in animal models reports altered excitability in the cerebral cortex 49 following FMRP loss (7-9), which may be due to mis-regulation of RNA targets encoding 50 synapse-associated proteins. While human pluripotent stem cell (hPSC) models of FXS hold 51 great promise for dissection of human disease relevant mechanisms and drug screening, they 52 have yielded diverse, and at times conflicting data on the impact of FMRP loss on human neurite 53 development, synaptic connectivity and intrinsic and synaptic properties (7, (10) (11) (12) . Even 54 fundamental measurements such as neurite outgrowth have been reported to be decreased (10, 55 11), increased (12) or unchanged (7) following FMRP loss in different hPSC models. A 56 combination of technical and experimental variables such as differences in genetic backgrounds, 57 constitutive versus inducible FMRP loss, different cell type(s) and cell ratios generated by 58 distinct in vitro differentiation paradigms, inclusion or exclusion of multiple additional cell types 59 in co-cultures such as mouse neurons or glia, and different time-points of analyses all likely 60 contribute to varying phenotypic presentations. This further implies that some FXS cellular 61 phenotypes may be sufficiently subtle as to not rise above these technical and biological sources 62 of variation (7), complicating cross study comparisons and extrapolation to the human disease 63 state in vivo. While the lack of congruity across studies presents a challenge, careful assessment 64 of different sources of variance will likely facilitate a more holistic view of the impact of FMRP 65 loss on neuronal development, synaptic connectivity and function in the human brain. In 66 particular, a majority of studies of the impacts of FMRP loss on physiological function focus on 67 a single time-point of analysis, which led us to consider the initial pathological changes due to 68 FMRP loss and how such changes dynamically evolve over different stages of differentiation. 69
Specifically, we utilized CRISPR-Cas9 technology to generate isogenic hPSC lines with 70 or without constitutive FMRP loss and used these cellular tools to generate excitatory cortical 71 neurons from a well-established in vitro differentiation paradigm (7, (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) . To gain insight into 72 the physiological response to FMR1 loss over the course of in vitro differentiation, we measured 73 intrinsic membrane properties and synaptic transmission in isogenic FMR1 y/+ and FMR1 y/-74 neurons at five separate time-points from two to five weeks of in vitro differentiation. We 75 identified significant cell intrinsic defects but not synaptic transmission deficits driven by FMRP 76 loss in these cellular systems. Moreover, these differences began to emerge relatively early 77 during in vitro differentiation and several metrics dynamically changed over time, which may 78 account for some of the previous discrepancies reported in the literature. 79
80

Results
81
To facilitate analyses of FMRP loss isolated from differences in genetic background, we first 82 generated and validated FMR1 y/+ and FMR1 y/isogenic hPSC lines (referred to as FMR1 WT and 83 FMR1 KO, respectively) by targeting exon 4 of FMR1 with CRISPR-Cas9 in the XY line H1 84 ( Fig. 1A) . Indels in exon 4 of FMR1 led to complete loss of FMRP expression ( Fig. 1B) and loss 85 of FMRP did not prevent hPSC differentiation into excitatory neurons (Fig. 1C) , consistent with 86 previous reports using a similar differentiation paradigm (7). Targeted cell lines maintained 87 pluripotency, tri-lineage potential and karyotype stability ( Fig. S1 and data not shown) . 88
89
To understand how constitutive loss of FMRP affects the electrophysiological profiles of 90 human excitatory neurons, we first assessed intrinsic membrane properties. For all whole-cell 91 patch clamp experiments, FMR1 WT and FMR1 KO neurons were plated at densities of 40,000 92 cells/cm 2 with mouse glia on glass coverslips. hPSCs used for in vitro differentiation were 93 infected with CAMK2A-GFP or CAMK2A-mOrange and only GFP+ or mOrange+ neurons 94 were used for patch clamp analyses in order to select for neurons sufficiently mature as to 95 express CAMK2A, as previously described (13). Neurons from each genotype were recorded 96 from up to five separate batches of in vitro differentiation at five separate time-points from days 97 11 to 35 (D11, D14, D21, D28 and D35) ( Fig. S2) . As shown in Fig. 2A , we first assessed 98 passive membrane properties of the neurons including: resting membrane potential (RMP), 99 membrane resistance (Rm), membrane time constant (Tau) and membrane capacitance (Cm). 100
From these properties, we observed significant differences in Rm and Cm in FMR1 KO 101 compared to FMR1 WT neurons, but no changes to RMP or Tau at any time-point measured 102 ( Fig. 2B-E) . Specifically, we observed decreased Rm and increased Cm in FMR1 KO neurons 103 relative to FMR1 WT neurons (Figs. 2C, E). However, only changes to Rm remained significant 104 across time from D14-D35 ( Fig. 2C) , while Cm appeared dynamic, with significant differences 105 observed at D14 and D35 and no significant differences at D11, D21 or D28 ( Fig. 2E) . While 106 both significant parameters (i.e., decreased Rm and increased Cm in FMR1 KO neurons relative 107 to FMR1 WT neurons) are consistent with FMR1 KO neurons showing an increased maturation 108 profile compared with age-matched FMR1 WT control neurons, they also suggest that the 109 neurons undergo dynamic shifts in their physiological properties over time in response to 110 constitutive FMR1 loss. Our data are also consistent with FMRP driving early (D14) changes to 111 intrinsic membrane properties. 112
We next assessed the active membrane properties of the neurons, including action 114 potential threshold (APthres), action potential half-width (APhw), action potential amplitude 115 (APamp), after hyperpolarization (AHP) and maximum frequency ( Fig. 3A) . From these 116
properties, we observed a significant increase in firing frequency at D21, D28 and D35 and 117 decreased APhw at D11 and D14 in FMR1 KO neurons relative to FMR1 WT neurons, with no 118 changes to APthres, APamp or AHP at any time-point measured ( Fig. 3B-G) . Significant 119 differences in APhw were evident early during in vitro differentiation at D11 and D14 but these 120 differences disappeared at later time-points ( Fig. 3B ), suggesting that neurons may undergoing 121 compensatory changes over time. Significant differences in firing frequency curves and 122 maximum frequency emerged after D21 and remained until D35 ( Fig. 3F-G) . As with decreased 123
Rm and increased Cm in FMR1 KO neurons relative to FMR1 WT neurons described above 124 ( Fig. 2C, E) , increased maximum frequency and decreased APhw are consistent with FMR1 KO 125
neurons showing an increased maturation profile compared with age-matched FMR1 WT control 126
neurons. 127
Finally, we measured synaptic transmission including mean amplitude and frequency of 128 synaptic events as well as the percentage of neurons with spontaneous excitatory post-synaptic 129 currents (sEPSCs) in the absence of the AP blocker tetrodotoxin (TTX) (Fig. 4) from the same 130 neurons used to assess intrinsic properties ( Figs. 2-3) . We did not detect differences in any of 131 these synaptic properties measured under steady state conditions ( Fig. 4A-D) . separate time-points, we observed subtle but significant differences in intrinsic membrane 137
properties that collectively suggest an increased physiological maturation profile of FMR1 KO 138 neurons compared to FMR1 WT controls, consistent with previous studies describing 139 electrophysiological and neural network activity in mouse models of FXS (23-28). Our results 140 suggest that early developmental changes in the intrinsic membrane properties could potentially 141 underlie subsequent cortical hyperexcitability and other related neurological deficits associated 142 with FXS. Given that human in vitro derived neurons most closely resemble prenatal cell stages 143 in vivo (13), these analyses underscore the importance for future studies to identify the ionic 144 cellular mechanisms underlying the hyperexcitability in FXS during prenatal development. Of 145 note, not all phenotypes were stable over time, and indeed we observed dynamic changes in 146 multiple metrics, suggesting that neurons respond to constitutive FMRP loss as they differentiate 147 in vitro and some discrepancies in the literature may be due to differing time-points of analysis. 148
Indeed, a majority of studies using in vitro human neuronal of disease assess electrophysiological 149
properties at a single time-point (7, 15, 16) . Although we detected significant differences in 150 intrinsic properties, we did not uncover alterations in synaptic function consistent with a previous 151 study of FXS using the same neuronal cell type (7). This suggests that additional cell types or 152 conditions may be required to unmask synaptic phenotypes in vitro. For example, our inclusion 153 of mouse glia increased the health and viability of our neuronal cultures, but could also reduce 154 phenotypic severity if glia contribute to electrophysiological phenotypes in FXS, as reported in 155 other experimental contexts (29) (30) (31) . While our experiments allow us to sensitively reveal 156 phenotypes specific to excitatory cortical neurons, they cannot capture the complex relationship 157 with inhibitory neurons and how this may drive network perturbations. Though our isogenic 158 system eliminates variability in genetic background between patient and control samples and 159 thus allows for the detection of more subtle phenotypes, given the variability reported in both 160 FXS molecular phenotypes (e.g., differing levels of protein synthesis changes across 161 patients)(32) as well as FXS clinical presentations (e.g., the fact that a subset of patients have 162 seizures and a subset do not)(33), physiological phenotypes in vitro may similarly vary across 163 different parental cell lines. Our study identifies specific time-points and conditions in human in 164 vitro derived cortical neurons for further investigation. Future studies will be required to fully 165 understand how different patient brain cell types respond to Institute (https://www.wicell.org). All studies using H1 followed institutional IRB and ESCRO 175 guidelines approved by Harvard University. Stem cell culture and assessment of pluripotency 176 and tri-lineage potential was carried out as previously described (35) (36) (37) . In brief, stem cells were 177 grown and maintained in mTeSR1 medium (Stem Cell Technologies) on geltrex-coated plates 178 (Life Technologies). Cells were routinely tested to confirm the absence of mycoplasma 179 contamination (Lonza MycoAlert). CRISPR-Cas9 based genome engineering experiments were 180 carried out as previously described (35) (36) (37) . In brief, H1 was transfected with pre-assembled 181
Cas9 protein (NEB) + crRNA and tracrRNA (Synthego), targeting full-length FMR1 upstream of 182 predicted functional domains (gRNA: GTTGGTGGTTAGCTAAAGTG), using the NEON 183 system (Life Technologies). Wild-type cells are those that went through the gene-targeting 184 protocol but were not edited. Antibodies used to assess pluripotency were anti-OCT3/4 (R&D 185 Systems AF1759), anti-SOX2 (BD 245619), and anti-TRA-1-60 (Santa Cruz Biotechnology sc-186 21705). Antibodies used to assess tri-lineage potential were anti-AFP (Sigma A8452), anti-SMA 187 (Sigma A2547), and anti-β-III-Tubulin (R&D Systems MAB1195). 188 189
Generation of human excitatory cortical neurons 190
Human neurons were generated as previously described (13, 14) . In brief, H1 hPSCs were internal solution containing in mM: 120 K-Gluconate, 2 MgCl2, 10 HEPES, 0.5 EGTA, 0.2 211 Na2ATP, and 0.2 Na3GTP. All experiments were performed at room temperature. The 212 recordings were made with a microelectrode amplifier with bridge and voltage clamp modes of 213 operation (Multiclamp 700B, Molecular Devices). Cell membrane potential was held at -60 mV, 214 unless specified otherwise. Signals were low-pass filtered at 2 kHz and sampled at 10kHz with a 215
Digidata 1440A (Molecular Devices). All data were stored on a computer for subsequent off-line 216 analysis. Cells in which the series resistance (Rs, typically 8-12 MΩ) changed by >20% were 217 excluded for data analysis. In addition, cells with Rs more than 25 MΩ at any time during the 218 recordings were discarded. Conventional characterization of neurons was made in voltage and 219 current clamp configurations. The membrane resistance, time constant (tau) and capacitance 220 were measured in current clamp mode as described previously (38) . CAMK2A expressing 221 neurons were identified for recordings on the basis of GFP or mOrange expression visualized 222 with a microscope equipped with GFP and Texas red filter (BX-51WI, Olympus). The 223 electrophysiologists were blinded to genotype until data analyses were complete. The number of 224 individual neurons recorded from and the number of independent batches of neurons are shown 225 in Fig. S2 
